Bone Marrow-Derived Mesenchymal Stem Cell Implants for the Treatment of Focal Chondral Defects of the Knee in Animal Models: A Systematic Review and Meta-Analysis

Abstract

Osteoarthritis remains an unfortunate long-term consequence of focal cartilage defects of the knee. Associated with functional loss and pain, it has necessitated the exploration of new therapies to regenerate cartilage before significant deterioration and subsequent joint replacement take place. Recent studies have investigated a multitude of mesenchymal stem cell (MSC) sources and polymer scaffold compositions. It is uncertain how different combinations affect the extent of integration of native and implant cartilage and the quality of new cartilage formed. Implants seeded with bone marrow-derived MSCs (BMSCs) have demonstrated promising results in restoring these defects, largely through in vitro and animal studies. A PRISMA systematic review and meta-analysis was conducted using five databases (PubMed, MEDLINE, EMBASE, Web of Science, and CINAHL) to identify studies using BMSC-seeded implants in animal models of focal cartilage defects of the knee. Quantitative results from the histological assessment of integration quality were extracted. Repair cartilage morphology and staining characteristics were also recorded. Meta-analysis demonstrated that high-quality integration was achieved, exceeding that of cell-free comparators and control groups. This was associated with repair tissue morphology and staining properties which resembled those of native cartilage. Subgroup analysis showed better integration outcomes for studies using poly-glycolic acid-based scaffolds. In conclusion, BMSC-seeded implants represent promising strategies for the advancement of focal cartilage defect repair. While a greater number of studies treating human patients is necessary to realize the full clinical potential of BMSC therapy, high-quality integration scores suggest that these implants could generate repair cartilage of substantial longevity.

Temporal control in shell–core structured nanofilm for tracheal cartilage regeneration: synergistic optimization of anti-inflammation and chondrogenesis

“…The selection of seed cells is of great significance for tracheal cartilage repair [ 58 ]. BMSCs, a commonly used cell type with definite chondrogenic capacity, were employed as seeding cells [ 59 ]. BMSCs can express various surface antigens, such as CD71, CD44, CD105, CD90 and SH2, SH3, etc.…”

Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Alleviate Rheumatoid Arthritis Symptoms via Shuttling Proteins

“…Nevertheless, to date, the pathogenesis of RA and the development of effective early diagnosis and treatment modalities remain largely unresolved, resulting in profound disability and premature mortality . Numerous studies have showcased the burgeoning interest in stem cell-based therapy for augmenting osseointegration efficiency in the RA, and BMSCs can alleviate the symptoms of RA, encompassing the inhibition of local inflammatory cytokines and enhancement of cartilage healing. , Our previous study demonstrated, for the first time, that IL-1β siRNA-BMSCs are more effective in repairing cartilage defects associated with RA than BMSCs alone. This finding suggests that IL-1β siRNA-BMSCs may represent a novel and promising strategy for the treatment of RA .…”

In situ fabrication of an anisotropic double-layer hydrogel as a bio-scaffold for repairing articular cartilage and subchondral bone injuries

“… 10 Cartilage tissue engineering assumes the construction of scaffold materials suitable for defect sites, the isolation of specific tissues or cells from the body, in vitro expansion and culturing, the inoculation of the expanded cells into a specific scaffold, and the reimplantation of the cartilage component carrying the seed cells into a defect site. 11 However, direct implantation of tissue-engineered scaffolds for articular cartilage repair can hardly achieve good results.…”